Nike surges after earnings beat, MediciNova soars after news on COVID-19 vaccine prototype Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Johnson & Johnson (JNJ) up 2% after announcing the launch of its multi-country Phase 3 ENSEMBLE trial for its COVID-19 vaccine candidate JNJ-78436735
- Gores Holdings IV (GHIV) up 6% after United Wholesale Mortgage and the company announced that they have entered into a definitive agreement with respect to a business combination, under which the combined company will operate under the UWM name and the Class A common stock will be listed on
Nasdaq
- MediciNova (MNOV) up 24% after
its intranasal SARS-CoV-2 vaccine prototype for COVID-19 induced systemic serum IgG and mucosal IgA neutralizing antibodies against the S1 antigen of SARS-CoV-2 in mice
UP AFTER EARNINGS -
- Nike (NKE) up 12%
- General Mills (GIS) up 1%
- Cintas (CTAS) up 2%
DOWN AFTER EARNINGS -
- Stitch Fix (SFIX) down 15%
- KB Home (KBH) down 1%
ALSO LOWER -
- Tesla (TSLA) down 2% after Battery Day event
- National Storage (NSA) down 4% after 4.5M share spot secondary offering priced at $33.15
- Aurora Cannabis (ACB) down 16% after reporting Q4 earnings and issuing Q1 guidance
Symbols:
JNJ GHIV MNOV GIS CTAS NKE SFIX KBH TSLA - $423.90 /
-25.41 (-5.66%)
NSA ACB Keywords: Fly Intel, Wall Street, Top Stories, Stocks